Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03417882 |
Title | GRN-1201 With Pembrolizumab in Subjects With Metastatic PD-L1+ NSCLC |
Recruitment | Terminated |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | BrightPath Biotherapeutics |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
St Joseph Hospital of Orange | Orange | California | 92868 | United States | Details | |
University of Colorado Cancer Center | Aurora | Colorado | 80045 | United States | Details | |
Florida Hosptial Cancer Center- AdventHealth | Orlando | Florida | 32804 | United States | Details | |
Robert H Lurie Cancer Center at Northwestern University | Chicago | Illinois | 60611 | United States | Details | |
University of Illinois at Chicago | Chicago | Illinois | 60612 | United States | Details | |
Orchard Healthcare | Skokie | Illinois | 60077 | United States | Details | |
Norton Healthcare Cancer Institute | Louisville | Kentucky | 40202 | United States | Details | |
East Jefferson General Hospital | Metairie | Louisiana | 70006 | United States | Details | |
Ocshner Cancer Institute | New Orleans | Louisiana | 70121 | United States | Details | |
Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | United States | Details | |
Virginia Cancer Institute | Richmond | Virginia | 23230 | United States | Details |